We are live on
!
Find out more
Holocene Advisors Portfolio holdings
AUM
$41.5B
1-Year Est. Return
42.97%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+42.97%
3 Year Est. Return
+132.57%
5 Year Est. Return
+195.68%
10 Year Est. Return
–
AUM
$24B
AUM Growth
-$3.28B
(-12%)
Cap. Flow
-$2.78B
Cap. Flow
% of AUM
-11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
884
New
192
Increased
181
Reduced
295
Closed
209
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$702M |
| 2 |
PepsiCo
PEP
|
+$352M |
| 3 |
Merck
MRK
|
+$320M |
| 4 |
Murphy USA
MUSA
|
+$254M |
| 5 |
Autodesk
ADSK
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$407M |
| 2 |
Target
TGT
|
+$346M |
| 3 |
Meta Platforms (Facebook)
META
|
+$302M |
| 4 |
Broadcom
AVGO
|
+$274M |
| 5 |
CarMax
KMX
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.12% |
| 2 | Consumer Discretionary | 16.62% |
| 3 | Technology | 15.43% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Staples | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
MoonLake Immunotherapeutics
MLTX
$1.49B
| $71.5M | 0.3% |
1,626,341
+171,472
| +12% | +$7.26M |
|
102
Datadog
DDOG
$101B
| $69.4M | 0.29% |
535,055
-108,520
| -17% | -$13.1M |
|
103
Reddit
RDDT
$29.9B
| $69.2M | 0.29% |
+1,082,868
| New | +$57.1M |
|
104
Spotify
SPOT
$99.2B
| $67.9M | 0.28% |
216,302
+158,546
| +275% | +$47.7M |
|
105
Enphase Energy
ENPH
$5.15B
| $67.1M | 0.28% |
672,641
-101,763
| -13% | -$11.9M |
|
106
Valero Energy
VLO
$87.1B
| $66.9M | 0.28% |
+426,571
| New | +$68.8M |
|
107
Option Care Health
OPCH
$3.55B
| $66.8M | 0.28% |
2,411,734
+137,002
| +6% | +$4.08M |
|
108
Revvity
RVTY
$12.8B
| $66.4M | 0.28% |
633,677
-130,233
| -17% | -$13.8M |
|
109
IDEAYA Biosciences
IDYA
$3.47B
| $65.7M | 0.27% |
1,871,873
+256,225
| +16% | +$10.1M |
|
110
Avantor
AVTR
$9.04B
| $65.2M | 0.27% |
3,075,946
-623,348
| -17% | -$15M |
|
|
SCHW
111
Charles Schwab
SCHW
$188B
| $65M | 0.27% |
882,517
+624,832
| +242% | +$46.2M |
|
112
Nucor
NUE
$62.6B
| $65M | 0.27% |
+411,242
| New | +$71.5M |
|
113
Vera Therapeutics
VERA
$2.18B
| $65M | 0.27% |
1,796,077
+588,697
| +49% | +$23.4M |
|
114
AT&T
T
$158B
| $65M | 0.27% |
+3,400,305
| New | +$59.1M |
|
115
Copart
CPRT
$26.8B
| $64.3M | 0.27% |
1,186,863
+410,252
| +53% | +$22.4M |
|
116
Cloudflare
NET
$104B
| $63.6M | 0.27% |
767,817
+677,335
| +749% | +$54.6M |
|
117
LPL Financial
LPLA
$28.3B
| $62M | 0.26% |
+221,958
| New | +$60.2M |
|
118
West Pharmaceutical
WST
$24.7B
| $61.3M | 0.26% |
186,133
-170,875
| -48% | -$60.4M |
|
119
PNC Financial Services
PNC
$102B
| $61.2M | 0.26% |
393,823
+210,280
| +115% | +$32.6M |
|
120
Marathon Petroleum
MPC
$86.9B
| $61.1M | 0.26% |
+352,121
| New | +$65.5M |
|
121
Citizens Financial Group
CFG
$31.1B
| $60.1M | 0.25% |
1,667,256
+1,347,856
| +422% | +$47M |
|
122
Cardinal Health
CAH
$56B
| $59.1M | 0.25% |
600,594
-402,826
| -40% | -$41M |
|
123
Biohaven
BHVN
$2.05B
| $58.9M | 0.25% |
1,696,355
+323,629
| +24% | +$12.8M |
|
124
Evolent Health
EVH
$346M
| $58.8M | 0.25% |
3,075,727
-115,576
| -4% | -$2.95M |
|
125
BioMarin Pharmaceuticals
BMRN
$11.6B
| $58.7M | 0.25% |
713,104
+517,108
| +264% | +$43M |
|
Similar funds
DB
HF
Holocene Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Holocene Advisors held 884 positions worth $24B, down 12% from $27.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Holocene Advisors withdrew a net $2.78B in Q2 2024, closing 209 positions and reducing 295 holdings. Its most notable exit was Target, an estimated $346M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Holocene Advisors opened a new position in PepsiCo worth $336M.
- Holocene Advisors's largest Q2 2024 buy was PepsiCo: 2,038,750 shares worth $336M.
- Holocene Advisors added most to Visa in Q2 2024, an estimated $702M increase.
- Holocene Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $407M.
- Holocene Advisors fully exited Target in Q2 2024, selling an estimated $346M.
- Holocene Advisors's ten largest holdings make up 17% of its $24B portfolio in Q2 2024.
- Holocene Advisors opened 192 new positions and closed 209 in Q2 2024.
- Holocene Advisors's portfolio value fell 12% quarter-over-quarter to $24B.
Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.